SCHEMBL7086762

SCHEMBL7086762

Nc1ccc2c(c1)C(=C(Nc1ccccc1)c1ccccc1)C(=O)N2

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 6/20 0.45
RET P07949 3/20 0.39
FLT3 P36888 1/20 0.39
ALK Q9UM73 1/20 0.39
BRD4 O60885 2/20 0.38
AKT1 P31749 1/20 0.38
AKT2 P31751 1/20 0.38
BRD2 P25440 1/20 0.38
RPS6KA3 P51812 1/20 0.38
CCNB2 O95067 1/20 0.38
CDK1 P06493 1/20 0.38
HSP90AA1 P07900 1/20 0.38
CCNB1 P14635 1/20 0.38
CCR6 P51684 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
GSK3B P49841 3/20 0.38
KDR P35968 1/20 0.38
TLK2 Q86UE8 4/20 0.37
JAK3 P52333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29643001 1.00 PDPK1 (0.45) PDPK1RETFLT3ALKBRD4
SCHEMBL7086761 1.00 PDPK1 (0.45) PDPK1RETFLT3ALKBRD4
SCHEMBL7082906 0.96 PDPK1 (0.47) PDPK1RETFLT3ALKBRD4
SCHEMBL7082903 0.96 PDPK1 (0.47) PDPK1RETFLT3ALKBRD4
SCHEMBL7087980 0.94 PDPK1 (0.50) PDPK1RETFLT3ALKBRD4
SCHEMBL7087977 0.94 PDPK1 (0.50) PDPK1RETFLT3ALKBRD4
SCHEMBL7082439 0.93 PDPK1 (0.45) PDPK1RETBRD4AKT1AKT2
SCHEMBL7082441 0.93 PDPK1 (0.45) PDPK1RETBRD4AKT1AKT2
SCHEMBL7089576 0.93 PDPK1 (0.45) PDPK1FLT3BRD4AKT1AKT2
SCHEMBL7086305 0.92 BACE1 (0.45) PDPK1RETFLT3ALKAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111285872-B Indole-2-ketone derivative and preparation method and application thereof 北京志健金瑞生物医药科技有限公司 2022-05-17 CN disclosed
CN-111285872-A Indole-2-ketone derivative and preparation method and application thereof 北京志健金瑞生物医药科技有限公司 2020-06-16 CN disclosed
EP-1071665-B1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-10-01 EP disclosed
EP-1071665-A1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES Boehringer Ingelheim Pharma KG (DE) 2001-01-31 EP disclosed
WO-1999052869-A1 SUBSTITUTED INDOLINONES HAVING AN INHIBITING EFFECT ON KINASES AND CYCLINE/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-21 WO disclosed